Pramana Pharmaceuticals Inc.
$136,500.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2020-2021
Canada
A lead optimization study to define a clinical candidate amongst a novel series of GPR119 agonists for the treatment of Type2 Diabetes and co-morbidities. This study has the potential to lead to the...